163 related articles for article (PubMed ID: 35687811)
1. Plasma-based assays distinguish hyperfibrinolysis and shutdown subgroups in trauma-induced coagulopathy.
Lawson MA; Holle LA; Dow NE; Hennig G; de Laat B; Moore HB; Moore EE; Cohen MJ; Bouchard BA; Freeman K; Wolberg AS
J Trauma Acute Care Surg; 2022 Nov; 93(5):579-587. PubMed ID: 35687811
[TBL] [Abstract][Full Text] [Related]
2. Dense and dangerous: The tissue plasminogen activator-resistant fibrinolysis shutdown phenotype is due to abnormal fibrin polymerization.
Dow N; Coleman JR; Moore H; Osborn ZT; Sackheim AM; Hennig G; Butenas S; Nelson MT; Moore EE; Freeman K
J Trauma Acute Care Surg; 2020 Feb; 88(2):258-265. PubMed ID: 31999655
[TBL] [Abstract][Full Text] [Related]
3. Elucidating the molecular mechanisms of fibrinolytic shutdown after severe injury: The role of thrombin-activatable fibrinolysis inhibitor.
Coleman JR; Moore EE; Kelher MR; Jones K; Cohen MJ; Banerjee A; Silliman CC
J Trauma Acute Care Surg; 2023 Jun; 94(6):857-862. PubMed ID: 36787438
[TBL] [Abstract][Full Text] [Related]
4. Human neutrophil elastase mediates fibrinolysis shutdown through competitive degradation of plasminogen and generation of angiostatin.
Barrett CD; Moore HB; Banerjee A; Silliman CC; Moore EE; Yaffe MB
J Trauma Acute Care Surg; 2017 Dec; 83(6):1053-1061. PubMed ID: 28837538
[TBL] [Abstract][Full Text] [Related]
5. Plasmin thrombelastography rapidly identifies trauma patients at risk for massive transfusion, mortality, and hyperfibrinolysis: A diagnostic tool to resolve an international debate on tranexamic acid?
Barrett CD; Moore HB; Vigneshwar N; Dhara S; Chandler J; Chapman MP; Sauaia A; Moore EE; Yaffe MB
J Trauma Acute Care Surg; 2020 Dec; 89(6):991-998. PubMed ID: 33230046
[TBL] [Abstract][Full Text] [Related]
6. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
[TBL] [Abstract][Full Text] [Related]
7. Hyperfibrinolysis drives mechanical instabilities in a simulated model of trauma induced coagulopathy.
Gosselin AR; White NJ; Bargoud CG; Hanna JS; Tutwiler V
Thromb Res; 2022 Dec; 220():131-140. PubMed ID: 36347079
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobin-based oxygen carriers promote systemic hyperfibrinolysis that is both dependent and independent of plasmin.
Morton AP; Moore EE; Moore HB; Gonzalez E; Chapman MP; Peltz E; Banerjee A; Silliman C
J Surg Res; 2017 Jun; 213():166-170. PubMed ID: 28601310
[TBL] [Abstract][Full Text] [Related]
9. Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient.
Moore EE; Moore HB; Gonzalez E; Sauaia A; Banerjee A; Silliman CC
Transfusion; 2016 Apr; 56 Suppl 2(Suppl 2):S110-4. PubMed ID: 27100746
[TBL] [Abstract][Full Text] [Related]
10. The role of activated coagulation factor XII in overall clot stability and fibrinolysis.
Konings J; Hoving LR; Ariëns RS; Hethershaw EL; Ninivaggi M; Hardy LJ; de Laat B; Ten Cate H; Philippou H; Govers-Riemslag JW
Thromb Res; 2015 Aug; 136(2):474-80. PubMed ID: 26153047
[TBL] [Abstract][Full Text] [Related]
11. Direct delivery of plasmin using clot-anchoring thrombin-responsive nanoparticles for targeted fibrinolytic therapy.
Sun M; Hao Pontius MH; Yang S; Pendekanti T; Raghunathan S; Shavit JA; Sen Gupta A
J Thromb Haemost; 2023 Apr; 21(4):983-994. PubMed ID: 36696210
[TBL] [Abstract][Full Text] [Related]
12. Plasma is the physiologic buffer of tissue plasminogen activator-mediated fibrinolysis: rationale for plasma-first resuscitation after life-threatening hemorrhage.
Moore HB; Moore EE; Gonzalez E; Wiener G; Chapman MP; Dzieciatkowska M; Sauaia A; Banerjee A; Hansen KC; Silliman C
J Am Coll Surg; 2015 May; 220(5):872-9. PubMed ID: 25840538
[TBL] [Abstract][Full Text] [Related]
13. Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: Results from a laboratory sub-study of the FEISTY trial.
Morrow GB; Feller T; McQuilten Z; Wake E; Ariëns RAS; Winearls J; Mutch NJ; Laffan MA; Curry N
Crit Care; 2022 Sep; 26(1):290. PubMed ID: 36163263
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic shutdown diagnosed with rotational thromboelastometry represents a moderate form of coagulopathy associated with transfusion requirement and mortality: A retrospective analysis.
David JS; Lambert A; Bouzat P; Incagnoli P; Geay-Baillat AM; Taverna XJ; Inaba K; Maegele M
Eur J Anaesthesiol; 2020 Mar; 37(3):170-179. PubMed ID: 31567468
[TBL] [Abstract][Full Text] [Related]
15. Reduced plasminogen binding and delayed activation render γ'-fibrin more resistant to lysis than γA-fibrin.
Kim PY; Vu TT; Leslie BA; Stafford AR; Fredenburgh JC; Weitz JI
J Biol Chem; 2014 Oct; 289(40):27494-503. PubMed ID: 25128532
[TBL] [Abstract][Full Text] [Related]
16. Disintegration and reorganization of fibrin networks during tissue-type plasminogen activator-induced clot lysis.
Meh DA; Mosesson MW; DiOrio JP; Siebenlist KR; Hernandez I; Amrani DL; Stojanovich L
Blood Coagul Fibrinolysis; 2001 Dec; 12(8):627-37. PubMed ID: 11734662
[TBL] [Abstract][Full Text] [Related]
17. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
[TBL] [Abstract][Full Text] [Related]
18. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
Wu JH; Diamond SL
Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
[TBL] [Abstract][Full Text] [Related]
19. Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients.
Cardenas JC; Matijevic N; Baer LA; Holcomb JB; Cotton BA; Wade CE
Shock; 2014 Jun; 41(6):514-21. PubMed ID: 24667610
[TBL] [Abstract][Full Text] [Related]
20. The α-globin chain of hemoglobin potentiates tissue plasminogen activator induced hyperfibrinolysis in vitro.
Morton AP; Hadley JB; Ghasabyan A; Kelher MR; Moore EE; Bevers S; Dzieciatkowska M; Hansen KC; Cohen MS; Banerjee A; Silliman CC
J Trauma Acute Care Surg; 2022 Jan; 92(1):159-166. PubMed ID: 34538821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
